RecruitingNCT01205815

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment


Sponsor

Vanderbilt-Ingram Cancer Center

Enrollment

3,000 participants

Start Date

Jun 3, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study stores leftover tissue and blood samples from melanoma (skin cancer) patients to create a research bank that helps scientists better understand the disease and develop more targeted treatments. **You may be eligible if...** - You have a confirmed diagnosis of melanoma - You are undergoing a test or procedure that may produce leftover tissue that can be stored for future research - OR you have already had such a procedure and have not yet been asked to participate **You may NOT be eligible if...** - You have severe anemia that makes blood draws unsafe (though you may still donate tissue) - You are unable or unwilling to provide consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTissue and blood collection

Tissue will be obtained from a previous biopsy if available, or if unavailable, tissue will be collected from a scheduled biopsy. About3-4 teaspoons of blood will be collected.


Locations(1)

Vanderbitl-Ingram Cancer Center

Nashville, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01205815


Related Trials